In this issue of Cell Stem Cell, Csaszar et al. (2012) develop a culture method that overcomes current limitations in ex vivo hematopoietic stem/progenitor cell expansion by continuously diluting inhibitory signaling factors and maintaining stem cell density. This approach enhances the generation of precursors with potential therapeutic utility
AbstractThe clinical potential of umbilical cord blood-derived stem and progenitor cells has been de...
SummaryClinical hematopoietic transplantation outcomes are strongly correlated with the numbers of c...
Summary: Ex vivo gene therapy based on CD34+ hematopoietic stem cells (HSCs) has shown promising res...
In this issue of Cell Stem Cell, Csaszar et al. (2012) develop a culture method that overcomes curre...
A recent Science paper reported a purine derivative that expands human cord blood hematopoietic stem...
A recent Science paper reported a purine derivative that expands human cord blood hematopoietic stem...
Attempts to improve hematopoietic reconstitution and engraftment potential of ex vivo-expanded hemat...
1051-1052Expansion of haematopoietic stem cells from various sources has gained importance so as to...
Attempts to improve hematopoietic reconstitution and engraftment potential of ex vivo-expanded hemat...
AbstractThe successful expansion of hematopoietic stem and progenitor cells (HSPCs) from umbilical c...
The use of CD34+ hematopoietic stem cells (HSC) for transplantation has been limited due to the low ...
Umbilical cord blood (UCB) is a well established alternative source of haematopoietic stem/progenito...
Expansion of hematopoietic stem cells (HSCs) for therapeutic purposes has been a “holy grail&#...
textabstractThe goal of this thesis research is to establish ex vivo expansion conditions for HSCs d...
Robust and large-scale expansion of umbilical cord blood stem cells in vitro is necessary for wideni...
AbstractThe clinical potential of umbilical cord blood-derived stem and progenitor cells has been de...
SummaryClinical hematopoietic transplantation outcomes are strongly correlated with the numbers of c...
Summary: Ex vivo gene therapy based on CD34+ hematopoietic stem cells (HSCs) has shown promising res...
In this issue of Cell Stem Cell, Csaszar et al. (2012) develop a culture method that overcomes curre...
A recent Science paper reported a purine derivative that expands human cord blood hematopoietic stem...
A recent Science paper reported a purine derivative that expands human cord blood hematopoietic stem...
Attempts to improve hematopoietic reconstitution and engraftment potential of ex vivo-expanded hemat...
1051-1052Expansion of haematopoietic stem cells from various sources has gained importance so as to...
Attempts to improve hematopoietic reconstitution and engraftment potential of ex vivo-expanded hemat...
AbstractThe successful expansion of hematopoietic stem and progenitor cells (HSPCs) from umbilical c...
The use of CD34+ hematopoietic stem cells (HSC) for transplantation has been limited due to the low ...
Umbilical cord blood (UCB) is a well established alternative source of haematopoietic stem/progenito...
Expansion of hematopoietic stem cells (HSCs) for therapeutic purposes has been a “holy grail&#...
textabstractThe goal of this thesis research is to establish ex vivo expansion conditions for HSCs d...
Robust and large-scale expansion of umbilical cord blood stem cells in vitro is necessary for wideni...
AbstractThe clinical potential of umbilical cord blood-derived stem and progenitor cells has been de...
SummaryClinical hematopoietic transplantation outcomes are strongly correlated with the numbers of c...
Summary: Ex vivo gene therapy based on CD34+ hematopoietic stem cells (HSCs) has shown promising res...
DOI
Add to ORKG